Speaker: Jeffrey Langland. Part one features in vitro observations on the treatment of herpes simplex virus (HSV). Drug treatments have favored the overuse of pharmaceuticals and the development of viral resistance, and have changed little since the 1980s. Our research in the SCNM lab indicates a new mechanism of action for Melissa officinalis, which may be more effective than commonly used pharmaceuticals for all forms of HSV. Part two reports in vitro comparisons of mechanisms of actions of pharmaceuticals and botanical compounds in the treatment of MRSA and other drug-resistant infections, with focus on beta-lactam and quinolone botanical compounds in Coptis and Salvia.

Related product: The PowerPoint for this recording is available here: 2018 Southwest Conference on Botanical Medicine: Conference Book Download (PDF)

Continuing Education for Naturopathic Physicians: This recording has been approved for 1.5 pharmacy CME credits by

• California Naturopathic Doctor's Association (CNDA)
• Oregon Board of Naturopathic Medicine (OBNM)
• Arizona SCNM (Southwest College of Naturopathic Medicine)

More information: CME for NDs: Southwest Conference 2018